Japan News
-
Chugai Pharma to set up sales unit in China
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2013
Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned dr...Read more
-
Astellas, FibroGen start CKD anemia trial in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...Read more
-
Cancer-specific killer T cells created from iPS cells
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2013
Singapore: Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan have succeeded, for the first ...Read more
-
Will Japan be able to reduce its generic drug prices?
Japan | Analysis | By BioSpectrum Bureau | 2 Comment | 21 May, 2013
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...Read more
-
Life Tech signs agreement with iPS Academia Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012
Singapore: Life Technologies has signed a non-exclusive agreement with iPS Academia Japan for its induced pluripotent st...Read more
-
Nagoya scientists discover new molecules that change circadian rhythm
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015
A team of chemists and biologists at the Institute of Transformative Bio-Molecules (ITbM), Nagoya University, Japan, hav...Read more
-
BioDiem protozoan drug to get Japanese patent
Japan | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...Read more
-
Eisai, Nihon Medi-Physics to work on dementia intervention
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015
Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement...Read more
-
R-Tech Ueno acquires right to develop Santen Pharma's ophthalmic solution
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015
R-Tech Ueno Ltd, headquartered in Tokyo, has acquired the right to develop and commercialize DE-105 from Santen Pharmace...Read more
-
French firm successfully completes Ph I trial of diabetes drug in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2015
Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully co...Read more
-
Tarceva tablets with Nexavar show no improvement
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: A phase III trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexava...Read more
-
Mylan signs a settlement agreement with OSI Pharma
Japan | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...Read more
-
Sale of wound care devices spurs in Asia-Pacific: Frost & Sullivan analysis report
Japan | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in...Read more
-
Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma
Japan | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015
Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...Read more
-
Japan approves Daiichi Sankyo's Cravit Injections
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015
Tokyo: Daiichi Sankyo Company, Limited has obtained approval for partial changes concerning a supplementary indication ...Read more
-
Synageva BioPharma seeks approval for Kanuma in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2015
NASDAQ-listed Synageva BioPharma Corp. has submitted the New Drug Application (NDA) for Kanuma (sebelipase alfa) to the ...Read more
-
Bayer's thrombosis drug approved in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015
Tokyo: Bayer HealthCare has announced that the company has received approval in Japan for its oral Factor Xa inhibitor X...Read more
-
Matt Kerr: Tough task ahead for APAC HR managers
Japan | Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...Read more
